FDA - McKnight's Long Term Care News


Also in the news for Tuesday, February 17

Nursing home doctor pleads guilty, admits to $600,000 in kickbacks … FDA releases compounding pharmacy draft documents … House bill would repeal Health Insurance Tax

Also in the news for Wednesday, February 4

Beloved nursing home therapy dog shot in Kansas … Food and Drug Administration is requesting a budget of $4.9 billion … System for monitoring side effects of prescription drugs is severely lacking, report says.

FDA approves XARELTO Starter Pack for DVT

FDA has approved the XARELTO Starter Pack™ for deep vein thrombosis or pulmonary embolism. The medication is use to reduce the risk of stroke or blood clots in those with atrial fibrillation not caused by a heart valve problem.

FDA approves weight management drug

The U.S. Food and Drug Administration has approved Contrave as a treatment for chronic weight management. Contrave is a combination of two FDA-approved drugs, naltrexone and bupropion, in an extended-release formulation.

Tim Mullaney

Good news for (yawn) shift workers and residents

Long-term care professionals around the country cheered wildly last week when the Food and Drug Administration approved Belsomra, a new sleep drug. Shift workers applauded the addition to their medicine cabinets, already well-stocked with sleep aids. “I’ve tried melatonin and Ambien, but I didn’t feel great on either one of those dr—” said certified nursing assistant Susie Sleepless, interrupted by a yawn.

Next post in News